G Curigliano MD PhD
@curijoey
Followers
7,247
Following
1,357
Media
540
Statuses
4,861
Giuseppe Curigliano, MD, PhD, Professor at University of Milan and Head of Phase I Division at IEO, ESMO Open EiC, Tweets are my own
Milan, Italy
Joined June 2015
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
スプリンターズS
• 88616 Tweets
LIVE YOUR DREAM APO
• 67519 Tweets
かるびCR
• 55250 Tweets
CRかるび
• 53184 Tweets
WIN AT TODAY SHOW
• 51089 Tweets
REBECCA SUPPORTING ACTRESS
• 42047 Tweets
YINWAR x VIF x TOPS
• 37179 Tweets
ナムラクレア
• 25874 Tweets
ショアキーパー
• 21029 Tweets
西村騎手
• 20926 Tweets
ジャック
• 20438 Tweets
YIBO PLAY WITH LACOSTE
• 15910 Tweets
I express my deepest gratitude to the
@myESMO
community, my esteemed colleagues, and friends for trusting me to serve as the next president of the Society.
We are committed to dedicating all our efforts to advancing oncology and improving the lives of our patients.
41
42
318
Thrilled to welcome
#ESMO2024
after a challenging year! A heartfelt thank you to the global medical oncology community for your unwavering support. Together, we’ll continue to advance the field and serve our global society with dedication and innovation
@myESMO
@oncodaily
10
20
272
See our article 👉Targeting pan-cancer RET fusions featured in the cover of
@NatureMedicine
. Many years of work, a stellar team and many patients who generously believed in the science of precision medicine.
@IEOufficiale
@LaStatale
8
39
233
Excited to share that the DESTINY-06 trial was presented at
#ASCO2024
and received fantastic feedback from our outstanding audience! A huge thank you to everyone who attended and supported our work in advancing cancer treatment. Together, we’re making strides in oncology!
3
23
172
Thrilled to announce the publication of the final overall survival data of DESTINY-03 in Nature Medicine, coinciding with its presentation at
#ASCO2024
! This marks a significant milestone in our fight against cancer. Thank you to everyone involved for your dedication and support!
4
34
155
Don't just teach your students to read.
• Teach them to question what they read, what they study.
• Teach them to doubt.
• Teach them to think.
• Teach them to make mistakes and learn from them.
• Teach them how to understand something.
• Teach them how to teach others
3
59
149
We just lost another giant of cancer care. Our friend Angelo Di Leo is no more with us. I will profoundly miss him!
@myESMO
@BIGagainstBC
@AIOMtweet
@ASCO
20
8
140
Investing in the next generation of oncologists is crucial for the future of cancer research. At
#ASCO2024
, let's continue to support and mentor young talents who will drive innovation and breakthroughs in oncology. Together, we can achieve more!
#YoungOncologists
#CancerResearch
4
23
125
Understanding breast cancer complexity to improve patient outcomes: The St. Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023 - Annals of Oncology
3
34
119
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies | npj Breast Cancer
3
54
117
The
#ASCO
meeting is about to begin, featuring breakthrough data on cancer treatment across various pathologies. Stay tuned for groundbreaking updates that could change the future of oncology!
#CancerResearch
#MedicalInnovation
#ASCO2024
1
16
110
Cancer Patients and Risk of Mortality for COVID-19
1
36
96
Thrilled to share the impressive results of DESTINY-06 at
#ASCO2024
! These findings represent a significant advance in cancer treatment and bring hope to many. Grateful for the hard work and dedication of our research team.
#Oncology
#CancerResearch
0
18
90
This is demonstration we need an agnostic approach for drugs with high therapeutic ratio! Please publish it
Worst nightmare as a patient/oncologist is to deal with brain🧠metastases.
Most drugs don’t penetrate the blood brain barrier & trials often exclude these patients.
👇🏾Our patient with a near complete response after just 1 dose of T-DXd.🙌🏾👏🏾🙌🏾👏🏾
#Cholangiocarcinoma
#HER2
➕➕➕
43
232
1K
2
14
89
Very proud to share this great paper with a star panel
@jsoriamd
@stolaney1
@dradityabardia
@JavierCortesMD
and my pupils
@PTarantinoMD
@CCortiMD
🎉🎉🎉💎💎💎Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
5
30
88
PALLAS trial: the addition of palbociclib to adjuvant ET did not prolong iDFS compared to ET alone in patients with early HR+/HER2- breast cancer.
Analyses of high clinical risk cohort, did not identify a population of patients receiving benefit from palbociclib
5
37
88
For 25 years, I've witnessed the profound impact of ESMO on nurturing the young generation of medical oncologists. Their unwavering support and inspiration are the pillars of our future in oncology. Let's continue to empower their bright minds 🌟
#FutureLeaders
#MentorshipMatters
#ESMOMembers
📢 Voting for the ESMO Presidency 2027-2028 is now open. Learn more about the candidates, Giuseppe Curigliano and Nadia Harbeck, and their vision for the Society. Cast your vote now.
👉
0
7
19
7
22
86
Excited for
#ASCO24
! The unveiling of DESTINY-06 data marks a significant milestone, offering new hope and improved outcomes for patients. Together, we're pushing the boundaries of oncology.
#CancerResearch
#Oncology
#DESTINY06
#PatientCare
0
13
81
The latest Italian
#coronavirus
confirmed numbers
-17550 positive
-1441 died
-8372 hospitalised with symptoms
-1518 in intensive care with ARDS
-7860 asymptomatic at home
5
44
77
The latest Italian
#coronavirus
numbers on March 23rd 2020
-63.927 positive
-6.077 died
-20.692 hospitalised
-3.204 in intensive care with ARDS
-26.522 positive at home (no data on symptoms)
But look at the epidemic curve in Lombardia... the epicentrum
@OncoAlert
9
39
79
0
32
74
Milano, la ricercatrice Stefania Morganti vola dallo Ieo a Boston: «Studierò i tumori considerati incurabili»
@corriere
from
@IEOufficiale
@LaStatale
to
@DFCI_BreastOnc
congrats!!!!!
2
5
72
ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial -
1
15
73
“A society grows great when older people plant trees whose shade they know they shall never sit in”
I truly believe that enhancing the careers of young oncologists is the best way to impact the lives of our patients and shape the future of global oncology
#nextgenoncologists
#ESMOMembers
, one day left to cast your vote for the ESMO President 2027-2028. Your participation is important, your vote is confidential and anonymous.
0
4
6
4
16
73
Sponsored by
@Roche
,
I would like to share a Tweetorial about recent important advances in the management of advanced/metastatic triple negative breast cancer (mTNBC)
#Tweetorial
#Oncology
#Cancer
#Diagnosis
#TNBC
#Immunotherapy
#PDL1
2
23
70
Curigliano (Ieo): «Cure dei tumori spesso in ritardo a causa del Covid. E tanti medici sono esauriti»
@corriere
@IEOufficiale
@LaStatale
0
22
69
Congratulations to Angela DeMichele, Scientific Chair of
#ASCO2024
, for an outstanding scientific program! Exciting to see so many new practice-changing data being presented.
#Oncology
#CancerResearch
#ASCO
#MedicalInnovation
"
@AngieDemichele
@ASCO
@OncoAlert
2
8
67
Proud to serve on the Educational Committee for
#ASCO2024
under the visionary and inclusive leadership of Dr. Lynn Schuchter
@ascopress
Together, we're shaping the future of oncology education and advancing cancer care for all.
#OncologyEducation
#Leadership
#ASCO
@OncoAlert
0
13
66
Congratulations to
@stolaney1
. She will be transformative!
Congratulations to Sara Tolaney, MD, MPH
@stolaney1
@df_hcc
on her appointment as
@ALLIANCE_org
Breast Committee Vice-Chair!
#AllianceSpring24
#NCI
#NCTN
#CancerResearch
15
13
74
1
6
63
Submit your abstract! If you are a breast cancer doctor, this is your meeting
@myESMO
@prat_aleix
@PTarantinoMD
@OncoAlert
@NicoleKuderer
@ErikaHamilton9
@stolaney1
#ESMOBreast22
: Onsite and Online Congress – Join the best scientists at this multidisciplinary meeting with a global scope. Last weeks to share your studies. Deadline 15 February 2022
#breastcancer
#TNBC
#bcsm
#mbcsm
#earlybreastcancer
@curijoey
0
14
35
1
23
63
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers | Nature Medicine
@OncoAlert
0
20
60
Gilberto we are all with you. Take care and I am here for any support you need. We all love you!
451
103
1K
2
9
62
Congratulations to Lillian Siu
@lillian_siu
the recipient of the
#ASCO24
Karnofsky Award! Her pioneering work in cancer research continues to inspire and drive advancements in oncology. A well-deserved honor for a true leader!
#CancerResearch
#Oncology
#ASCOAwards
2
6
61
The best gift I can receive from my fellows! They are our future!
1
5
60
How to survive the fake news about cancer
0
34
58
The latest Italian
#coronavirus
confirmed numbers on March 15th 2020
-24.747 positive
-1809 died
-9663 hospitalised with symptoms
-1672 in intensive care with ARDS
-9268 asymptomatic at home
8
42
56
Treatment Choice: How to Sequence New Antibody-Drug Conjugates in HER2-Negative Breast Cancer
0
10
59
Our friend
@FAndreMD
@myESMO
@GustaveRoussy
@IEOufficiale
@LaStatale
a long journey to precision medicine in cancer care and
@FAndreMD
was a pioneer! Thanks for your friendship
0
6
57
@IEOufficiale
Ranked 9th best cancer center in the world: Innovation and research to impact on cancer patients outcome
@myESMO
@ASCO
@AACR
3
10
56
What an incredible experience at
#ASCO2024
! Thrilled to have connected with so many inspiring friends and colleagues. Here's to advancing oncology together! 🌟
#CancerResearch
#MedicalCommunity
#Networking
#Oncology
#ASCO
0
8
55
Are all cyclin-dependent kinases 4/6 inhibitors created equal? | npj Breast Cancer
@OncoAlert
0
17
54
Honored to present LBA1000 at ASCO. This advancement is a game-changer in oncology, offering new hope for patients.
#BreastCancerAwareness
#HER2Low
#ADCTherapy
Dear Colleagues,
The
@OncoAlert
🚨Network Presents OUR Picks of
TOP 🔟Abstracts to be Presented at
#ASCO24
This List Curated by:
#OncoAlertAF
Leads :
@ElisaAgostinett
🇧🇪
@to_be_elizabeth
🇮🇹
@weoncologists
🇺🇸
With our distinguished OncoAlert Faculty:
@ErikaHamilton9
🇺🇸
@DrSGraff
0
50
95
0
8
55
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline thanks to
@MarkRobsonMD
for his leadership and to
@ASCO
staff for support
0
13
55
What to expect: Oncology’s response to coronavirus in Italy
0
21
53
@OncoAlert
#covid_19italia
my wife, an intensive care doctor with her staff, they are heroes in a COVID ICU
1
2
54
Celebrating Gender Equity and Inclusion with the inspiring
@DrDonSDizon
at
#ASCO2024
! Together, we’re making strides towards an inclusive and equitable future in oncology. Proud to stand with the Editor-in-Chief of
@CACancerJournal
#GenderEquity
#Inclusion
#Oncology
"
@OncoAlert
0
7
53
OS benefit with ribociclib and endocrine therapy in endocrine sensitive ER positive MBC with survival rate of 44%!
0
7
53
Grateful to
@SKyriakidesEU
Commissioner for Health at
@EU_Commission
for visiting
@IEOufficiale
and for her compassion and humanity with our patients
1
6
52
Don't miss the
#ASCO24
Educational Session on Biomarkers of Response to Antibody Drug Conjugates! Join us to explore the latest breakthroughs and their impact on personalized cancer therapy. Hall D1 at 1.15 pm. Stay ahead in oncology!
#ADC
#PrecisionMedicine
#OncologyEducation
2
15
51
@myESMO
ESMO Open has increased from 8.7 to 11.7 and gone up from 64/366 to 46/404 in the oncology category ranking. It has moved from the 82nd to the 88th percentile. Thanks past editors and to our stellar editorial board
@myESMO
@PTarantinoMD
4
4
50
On the role of p value New Guidelines for Statistical Reporting in the Journal | NEJM
@OncoAlert
1
19
50
@SABCSSanAntonio
great discussion of INAVO120 by
@hoperugo
. Wonderful to see very encouraging data with fulvestrant / palbo /inavo- although early. What’s next?
0
2
36
@ASCO
uploading my discussion on
#COVID
ー19 and Cancer for
#Asco2020
Virtual Meeting
@IEOufficiale
@LaStatale
2
6
50
With a special section od ADCs
2023 MASCC and ESMO guideline update for the prevention of chemotherapy and radiotherapy induced nausea and vomiting
@myESMO
@ESMO_Open
0
64
106
1
5
48
@OncoAlert
@myESMO
A new standard of care for TNBC: ASCENT trial shows that Sacituzumab govitecan significantly improves progression-free and overall survival with manageable safety versus chemotherapy in
metastatic triple-negative breast cancer.
1
20
48
@myESMO
Jose Baselga made an incredible impact on drug development and his work impacted the lives of many patients. He mentored many junior faculty that today are global key opinion leaders
@JavierCortesMD
. He inspired my generation! Thoughts are with his family.
0
6
48
Escalating and De-escalating Therapy for Early-Stage HER2-Positive Breast Cancer
0
17
48
The latest Italian
#coronavirus
confirmed numbers on March 22 2020
-59.138 positive
-5.476 died
-19.846 hospitalised with symptoms
-3.009 in intensive care with ARDS
- 23.783 positive at home (no data on symptoms)
@OncoAlert
4
29
46
Estimating the Benefits of Therapy for Early Stage Breast Cancer The St Gallen International Consensus Guidelines for the Primary Therapy of Early Breast Cancer 2019
@OncoAlert
3
21
47
Thank you,
@OncoAlert
! I am thrilled to accept this challenge and bring my vision for the future of our global
@myESMO
community!Let's make a difference together! 🌍
Dear Colleagues,
VOTING has NOW started for
@myESMO
President 2027-28 and will Remain Open until June 10, 2024.
The Candidates are🚨OncoAlert Faculty:
✅Prof. Nadia Harbeck
@Prof_Nadia_H
🇩🇪
➡️Director of
@LMU_Muenchen
#BreastCancer
Center
&
✅Prof. Giuseppe Curigliano
@curijoey
0
15
35
1
10
47
Variant allele frequency: a decision-making tool in precision oncology...a thread
2
15
46
Dr. Angelo Di Leo was awarded with the
@myESMO
Lifetime Achievement Award 2019 in tribute to his outstanding career dedicated to cancer research and education.
This is a very very sad news. Angelo was an incredibly nice person. Always quiet, smiling and helpful. I learnt a lot from him during our work
@BIGagainstBC
. Also, he was so elegant and charismatic
(credit photo: BIG , Brussels 2012)
4
8
93
0
7
45
The latest Italian
#coronavirus
confirmed numbers on March 16 2020
-27.980 positive
-2158 died
-11.025 hospitalised with symptoms
-1851 in intensive care with ARDS
-10.197 asymptomatic at home
4
30
43
#MORPHEUSpanBC
phase I multi center, randomised, umbrella study combining SG and Atezeo meets primary endpoint—ORR—in patients with metastatic PDL1+ TNBC.
#ESMOBreast24
#ESMOAmbassador
@myESMO
0
10
44
A new support from
@myESMO
to guide our members in the optimal care of our patients!
ESMO launched the Living Guidelines. This new online tool is designed to support optimal decision-making in the rapidly evolving oncology field, making it easier to use in doctors' routine clinical practice .
👉
#ESMOLivingGuidelines
@curijoey
1
15
57
0
5
44
A global effort to provide guidance when no high level evidence is available
@DrHBurstein
@MichaelGnant
@Merregan
Understanding breast cancer complexity to improve patient outcomes: The St. Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023
#bcsm
0
13
51
0
14
44
Best Specialized Hospitals 2022 - Oncology
@IEOufficiale
10th best cancer hospital in the world!
@curijoey
@GPravettoni
@PTarantinoMD
@darioT_
@APassaroMD
Best Specialized Hospitals 2022 - Oncology
2
14
41
We will wait for you in Berlin
@myESMO
#ESMOBreast22
: Onsite and Online Congress – Share your studies by 15 Feb & join the best scientists at this multidisciplinary meeting w/ a global scope
👉
@curijoey
@FallowfieldLJ
@LoiSher
@MOliveira_MD
@ines_vazluis
#bcsm
#breastcancer
#cancerresearch
1
8
15
1
8
42
Proud to be part of this panel of top italian scientists under the leadership of Franco Locatelli
@MinisteroSalute
#Consiglio
Superiore di Sanità
1
3
42
Trastuzumab deturuxtecan has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of unresectable or metastatic hormone receptor positive HER2 low or HER2 ultralow (IHC >0 <1+) breast cancer patients who never received CT according to DESTINY 06 study
1
9
43
The ESMO living Guidelines’s reduce the gap between clinical research and clinical practice!
@myESMO
0
4
42
Stefania is a brilliant breast oncologist and I am sure she will impact!
Big welcome to the
@DanaFarber
@nlinmd
@hthrparsons
family to Dr. Stefania Morganti, breast medical oncology fellow from Milano
@IEOufficiale
🇮🇹 always a pleasure exchanging ideas in Italian
8
4
105
0
1
42
Outstanding and innovative work of
@stefimorganti
@JCO_ASCO
@ASCO
@LaStatale
@IEOufficiale
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer | Journal of Clinical Oncology
1
12
41
Unlocking the Potential: Biomarkers of Response to Antibody-Drug Conjugates | American Society of Clinical Oncology Educational Book a must read
2
11
39
A milestone in clinical science! CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis | NEJM
1
7
38
I ricercatori italiani nella lista degli scienziati più citati al mondo. Nella classifica Clarivate nomi noti ai lettori di Fortune Italia.
1
1
39